Breaking News
Investing Pro 0
Cyber Monday Extended SALE: Up to 60% OFF InvestingPro+ CLAIM OFFER
Close

Croda International PLC (CRDA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
6,922.0 +128.0    +1.88%
01/12 - Closed. Currency in GBP ( Disclaimer )
  • Volume: 206,584
  • Bid/Ask: 6,000.0 / 7,500.0
  • Day's Range: 6,914.0 - 7,038.0
Type:  Equity
Market:  United Kingdom
ISIN:  GB00BJFFLV09 
SEDOL:  BJFFLV0
Croda Intl 6,922.0 +128.0 +1.88%

CRDA Financial Summary

 
See below for an overview of the Croda financial reports. To explore the data further, select a tab to navigate onto a specific report page. Choose to view either annual or quarterly report data.

Croda International Plc reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was GBP 1,127.3 million compared to GBP 934 million a year ago. Net income was GBP 543.5 million compared to GBP 153.4 million a year ago. Basic earnings per share from continuing operations was GBP 3.896 compared to GBP 1.1 a year ago. Diluted earnings per share from continuing operations was GBP 3.888 compared to GBP 1.098 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

CRDA Income Statement

Gross margin TTM 48.22%
Operating margin TTM 23.88%
Net Profit margin TTM 34.13%
Return on Investment TTM 12.34%
 Total Revenue  Net Income
Period Ending: Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021
Total Revenue 563.65
Gross Profit 268 234.2
Operating Income 141.65 141.65 107.1
Net Income 271.75

CRDA Balance Sheet

Quick Ratio MRQ 2.25
Current Ratio MRQ 3.02
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 47.39%
 Total Assets  Total Liabilities
Period Ending: Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021
Total Assets 4118.2 4118.2 3293.4 3293.4
Total Liabilities 1745 1527.5 1527.5
Total Equity 2373.2 2373.2 1753.1 1765.9

CRDA Cash Flow Statement

Cash Flow/Share TTM -
Revenue/Share TTM -
Operating Cash Flow  7.13%
 Cash  Net Change in Cash
Period Ending: Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 39.95 39.95
Cash From Investing Activities 269.55 269.55 -216.2
Cash From Financing Activities 27.35 -53.35
Net Change in Cash 339.95
* In Millions of GBP (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CRDA Comments

Write your thoughts about Croda International PLC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Mo Ahmadi
Mo Ahmadi Jan 13, 2022 16:08
Saved. See Saved Items.
This comment has already been saved in your Saved Items
falling knifive!!why?
Al Al
Al Al Jul 27, 2021 12:14
Saved. See Saved Items.
This comment has already been saved in your Saved Items
+6% today. Great company with a strong future.
Mike Liv
R2D2 Apr 02, 2021 22:46
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Excellent article in Shares Magazine ,01/04/2021, about Croda this week, worth a read. Pfizer contract a new revenue stream plus MRNA vaccines related work . chemicals firm Croda - ahighly exciting stock whichshould provide substantialmulti-year returns for investors.What’s firing our excitementis the new-found expertise inits healthcare division in socalledlipid nanoparticles orLNPs, which are fatty moleculesused in drugs and vaccines toencase and protect the stuff inthe drugs and vaccines that helppeople.Investors should buychemicals firm Croda - ahighly exciting stock whichshould provide substantialmulti-year returns for investors.What’s firing our excitementis the new-found expertise inits healthcare division in socalledlipid nanoparticles orLNPs, which are fatty moleculesused in drugs and vaccines toencase and protect the stuff inthe drugs and vaccines that helppeople.chemicals firm Croda - ahighly exciting stock whichshould provide substantialmulti-year returns for investors.What’s firing our excitementis the new-found expertise inits healthcare division in socalledlipid nanoparticles orLNPs, which are fatty moleculesused in drugs and vaccines toencase and protect the stuff inthe drugs and vaccines that helppeople.Investors should buychemicals firm Croda - ahighly exciting stock whichshould provide substantialmulti-year returns for investors.What’s firing our excitementis the new-found expertise inits healthcare division in socalledlipid nanoparticles orLNPs, which are fatty moleculesused in drugs and vaccines toencase and protect the stuff inthe drugs and vaccines that helppeople.
Rofik Ali
Rofik Ali May 13, 2020 3:06
Saved. See Saved Items.
This comment has already been saved in your Saved Items
very expensive
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email